Le Lézard
Classified in: Health, Science and technology, Covid-19 virus

DrOwl's Free Screening and Monitoring Tool To Be Used By Texas Schools To Help Keep Staff and Students Safe


ALBUQUERQUE, N.M., Aug. 4, 2020 /PRNewswire-PRWeb/ -- DrOwl, a medical platform built on patented technology, has provided a free electronic screening and monitoring tool to Texas schools. Our technology is helping schools throughout the state make their activities safer for staff, students, and guests, in the wake of the COVID-19 pandemic.

National attention has focused on recent spikes in Coronavirus outbreaks. As a result, contact tracing, which DrOwl offers, has become mission-critical for every organization. This precautionary measure, along with others, helps assure both employees, and visitors alike, that it's safe to go to school.

The first step that schools can do to protect employees and students is to follow the recommended CDC guidelines, which clearly state that everyone should be screened for both symptoms and history of exposure to COVID-19. This is the first step in contact tracing. DrOwl provides this enhanced measure of security and safety for those who use it.    

Many schools currently use paper tracking methods to screen those entering their facility to see if they have symptoms. Typically, each person fills out a piece of paper, which leaves the facility with a stack of papers to keep track of in order to compile into a visitor log. Proper tracking is very challenging with a paper method, especially when time is of the essence because of a COVID-19 positive diagnosis. This is why paper tracking could increase a school's potential liability.

DrOwl's groundbreaking technology solves the problems associated with paper-based contact tracing. At a time when every moment counts, DrOwl is helping keep employees, students, and guests safe in real-time. With DrOwl, everyone can electronically "check-in" and answer a list of questions screening for symptoms and a history of exposure to COVID-19 before they're able to enter the school.

"As a technology company, we are thrilled to use our skills and expertise to help during this crisis. We understand the importance of a solid screening process and that it is one of the things that is helping get us get back to school in a safe, well-thought manner," said Arvind Raichur, CEO, and Co-Founder of DrOwl. "Our screening tool is a game-changer for schools, businesses, and so many other organizations throughout the world."

Some of DrOwl's main features include:

"My entire club would not be practicing if it weren't for DrOwl. From before the time the Coronavirus made us shut our doors to now, we have always put the safety of our athletes and staff first. After reopening, we implemented COVID-safe practices, beginning with our screening through DrOwl. DrOwl not only fits our requirements but exceeds them, making the screening process quick and easy for us. Knowing that we're giving our athletes and staff the best chance of staying healthy, while keeping our teams and facility going, makes all the difference in the world to these athletes and their families," said volleyball coach Christina Norton, who has already been using DrOwl in a neighboring state.

DrOwl is a HIPAA-compliant tool specifically designed to securely sync and share medical records on demand. Our proprietary platform integrates AI and machine learning into our customized Patient Portal. DrOwl users can include caregivers or family members in their healthcare decision-making by sharing permission-based access to their personal Patient Portal. They can also initiate telehealth sessions, and allow caregivers or family members to join their secure telemedicine video calls. This is currently available in select areas, with other locations coming online shortly.

The DrOwl tool was designed to help keep both employees and students safe. And although nothing is foolproof, good methods of screening can help keep everyone safe and may reduce a school's potential liability from any exposure or outbreak at their facility.

Other Schools and businesses can go to CheckIn.DrOwl.com to learn more about this technology. And, users can download DrOwl.com for free from the iTunes or Google Play app stores.

About DrOwl

DrOwl is a medical platform built on patented technology, that provides a safe place to store your medical records. It was built to store, organize, search, and share your digital medical records on demand.

Once a user securely stores their medical records, DrOwl uses AI and machine learning to provide users with a Patient Portal based on the Patient's health records that include trusted, doctor-approved sources of information that is customized for each user and makes their medical information easier to understand. DrOwl users can also share their customized Patient Portal with caregivers or family members to include them in the patient's healthcare decisions. Users can initiate telehealth sessions and allow their caregivers or family members to join in the secure telemedicine video call.

DrOwl provides a free electronic screening solution to help protect schools and businesses. DrOwl's free screening tools allows organizations to screen their employees, vendors, and visitors in order to keep their workforces and facilities as safe as possible.

 

SOURCE DrOwl


These press releases may also interest you

at 12:15
The "Biologics Contract Development Market Size, Share & Trends Analysis Report by Source (Mammalian, Microbial), by Product Service Type, by Disease Indication (Oncology, Immunological Disorders), by Region, and Segment Forecasts, 2020 - 2027"...

at 12:07
Jackson Healthcare®, a family of highly specialized healthcare staffing, search and technology companies, today announced its inclusion on the Atlanta Business Chronicle's newly-published 2020 list of Atlanta's Healthiest Employers. The organization...

at 12:04
Reference is made to the stock exchange announcements on 23 September 2020 where Nordic Nanovector ASA (the "Company") announced that the Company had carried out a successful private placement raising gross proceeds of approximately NOK 231 million...

at 12:00
Medscape Education has been selected as a partner in hosting The Heart Failure Society of America (HFSA) Virtual Annual Scientific Meeting 2020, September 30-October 6. ...

at 12:00
The "Follicular Lymphoma - Market Insights, Epidemiology and Forecast to 2030" report has been added to ResearchAndMarkets.com's offering. Follicular Lymphoma Market Insights, Epidemiology and Forecast to 2030 delivers an in-depth understanding of...

at 12:00
Dracen Pharmaceuticals, Inc., a clinical stage privately-funded biotech company developing anti-cancer drugs, today announced the initiation of its first-in-human Phase 1/2a clinical trial of DRP-104. "Tumors are constantly growing and changing...



News published on 4 august 2020 at 06:55 and distributed by: